Advisor Group’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $10K | Sell |
182
-21,284
| -99% | -$1.17M | ﹤0.01% | 4368 |
|
|
2019
Q3 | $848K | Sell |
21,466
-5,213
| -20% | -$206K | 0.01% | 1247 |
|
|
2019
Q2 | $1.1M | Buy |
26,679
+12,777
| +92% | +$525K | 0.01% | 1079 |
|
|
2019
Q1 | $647K | Buy |
13,902
+9,646
| +227% | +$449K | 0.01% | 1411 |
|
|
2018
Q4 | $186K | Buy |
4,256
+3,606
| +555% | +$158K | ﹤0.01% | 2142 |
|
|
2018
Q3 | $37K | Sell |
650
-21,198
| -97% | -$1.21M | ﹤0.01% | 3502 |
|
|
2018
Q2 | $1.06M | Buy |
21,848
+2,524
| +13% | +$122K | 0.01% | 829 |
|
|
2018
Q1 | $755K | Buy |
19,324
+19,231
| +20,678% | +$751K | 0.01% | 1040 |
|
|
2017
Q4 | $3K | Sell |
93
-1,616
| -95% | -$52.1K | ﹤0.01% | 4610 |
|
|
2017
Q3 | $65K | Sell |
1,709
-6,610
| -79% | -$251K | ﹤0.01% | 2745 |
|
|
2017
Q2 | $253K | Sell |
8,319
-35
| -0.4% | -$1.06K | ﹤0.01% | 1609 |
|
|
2017
Q1 | $221K | Buy |
8,354
+4,551
| +120% | +$120K | ﹤0.01% | 1585 |
|
|
2016
Q4 | $97K | Buy |
3,803
+2,101
| +123% | +$53.6K | ﹤0.01% | 2091 |
|
|
2016
Q3 | $61K | Buy |
1,702
+1,576
| +1,251% | +$56.5K | ﹤0.01% | 2371 |
|
|
2016
Q2 | $3K | Buy |
+126
| New | +$3K | ﹤0.01% | 4007 |
|